Faringosept tablets with mint flavor 10mg, No. 20

Faringosept tablets with mint flavor 10mg, No. 20; 'Symptomatic treatment of infectious and inflammatory diseases of the oral cavity and pharynx: tonsillitis, gingivitis, stomatitis, pharyngitis.

Locally.

The tablets should be resorbed until they are completely dissolved (15-30 minutes after eating).

After using the tablets, you should refrain from drinking and eating for 3 hours.

Adults: 4-5 tablets (0.04-0.05 g) per day.

Children: from 3 to 7 years old, 3 tablets (0.03 g) per day. The course of treatment is 3-4 days.

Each mint-flavored lozenge contains:

Active ingredient: ambaeona monohydrate 10.0 mg.

Excipient sucrose 729.0 mg. lactose monohydrate 139.0mg. cocoa beans powder 50.0 mg, povidone K-30 50.0 mg, peppermint flavor 12.0 mg. stearic acid 10.0 mg.

• Hypersensitivity to ambazon and other components of the drug;

• intolerance to lactose, fructose, sucrase / isomaltase deficiency, glucose-galactose malabsorption, lactase deficiency;

• children up to age 3 years.

Pharmacodynamics

Has a bacteriostatic effect. Has a local and antimicrobial effect. It is active against a number of gram-positive microorganisms (Streptococcus haemolyticus, Streptococcus viridans, Pneumococcus). It does not affect the intestinal microflora.

Pharmokinetics

The optimal therapeutic concentration in saliva is achieved on the 3-4th day of taking the drug at a dose of 0.03-0.05 g / day. Overdose Cases of overdose of ambazon are unknown. There is no antidote. Possible overdose can lead to symptoms of gastrointestinal discomfort. When using an excessive dose, it is recommended to flush the stomach.

Side effects

Allergic reactions to the components of the drug, skin rash. If any of the side effects indicated in the instructions are aggravated, or you notice any other side effects not indicated in the instructions, inform your doctor.

Special conditions

Do not use the drug if you have increased individual sensitivity to any component that is part of the drug. The drug is not recommended for patients with hereditary sucrose and lactose intolerance. Increasing the dose does not have a greater clinical effect. If symptoms persist or if you have a fever or headache, see your doctor.

Influence on the ability to drive vehicles, mechanisms

The drug does not affect the ability to drive vehicles and mechanisms, as well as to engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.

Drug interactions

No clinically significant interactions with other drugs have been identified.